Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Clinical trial NCT05580341 · UNKNOWN

Trial details

NCT number: NCT05580341
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Genital Wart CIN VIN Papillomavirus Infections

Start date: 2022-09-01
Primary completion: 2023-06-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.